Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market

News provided by

Oct 26, 2023, 21:30 ET

DUBLIN, Oct. 26, 2023 /PRNewswire/ -- The "Global Laryngeal Cancer Therapeutics Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.

The global laryngeal cancer therapeutics market is poised for substantial growth, with a projected increase of USD 575.25 million during the period 2022-2027, accelerating at a robust CAGR of 5.43%.

This forecast is outlined in the comprehensive report on the laryngeal cancer therapeutics market, providing an all-encompassing analysis, including market size, trends, growth drivers, challenges, and an extensive vendor analysis featuring approximately 25 prominent companies in the industry.

The report offers an up-to-date analysis of the current market scenario, highlighting the latest trends, pivotal drivers, and the overall market environment. The laryngeal cancer therapeutics market is driven by factors such as the increasing prevalence of laryngeal cancer, a growing number of reimbursement programs, and rising awareness and early detection of this type of cancer.

Segmentation of the laryngeal cancer therapeutics market includes:

By Type

Biologics
Small Molecules

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

One of the key drivers fueling the growth of the laryngeal cancer therapeutics market is the advent of novel therapies. Additionally, the increasing prevalence of precision medicine and the presence of novel therapies in the pipeline for treatment are expected to contribute to substantial market demand in the coming years.

The report on the laryngeal cancer therapeutics market encompasses the following key areas:

Laryngeal Cancer Therapeutics Market Sizing
Laryngeal Cancer Therapeutics Market Forecast
Laryngeal Cancer Therapeutics Market Industry Analysis

The report provides a comprehensive vendor analysis, featuring prominent industry players, including:

Accord Healthcare Ltd.
Amgen Inc.
AstraZeneca Plc
Athenex Inc.
Bayer AG
Bristol Myers Squibb Co.
Celldex Therapeutics Inc.
Eli Lilly and Co.
F. Hoffmann La Roche Ltd.
Fresenius SE and Co. KGaA
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hanmi Pharm Co. Ltd.
Hikma Pharmaceuticals Plc
Merck and Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/v37i82

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets